The size of the European Atrial Fibrillation Surgery Market is predicted to worth USD 0.40 Billion in 2022. It is expected to grow at a CAGR of 13.1% to reach USD 0.73 million by 2027. The U.K leads the market due to the growing occurrences of atrial fibrillation and increasing health awareness.
A growing number of patients affected with atrial fibrillation in the European countries, acceptable regulations supporting the increasing utilization of catheter, and surgical ablation treatments of atrial fibrillation are the factors escalating the atrial fibrillation surgery market of Europe. The regularity of atrial fibrillation and less treatment cost support the mounting are leveling the market demand. Around 10 million people in Europe live with atrial fibrillation, published by the European Heart Network journal. Factors like developed healthcare infrastructure and accessibility of skilled labor are boosting up the demand of the market. A regular increase in obesity is propelling the growth rate of the atrial fibrillation surgery market. An increase in healthcare expenditure and growing disposable income is likely to add fuel to the region's market growth. Moreover, the minimized death rate and positive results of atrial fibrillation devices are estimated to mount the market growth in the area over the period.
Lack of awareness regarding the surgeries associated with atrial fibrillation and accessibility of few pharmaceutical replacements are likely to hinder the market. However, the cost of the treatment procedure is impeding the market demand. Lack of experienced professionals needed at the time of treatment of performing surgery is acting as an excellent barrier for the growth of the atrial fibrillation market in Europe.
This research report on the Europe Atrial Fibrillation Surgery Market has been segmented and sub-segmented into the following categories:
The European market was positioned as second largest in 2019 in the global atrial fibrillation surgery market and predicted to continue growing throughout the forecast period. The growth of the region is attributed due to reimbursement schemes, and the rise in prominence for surgeries is fueling the market growth throughout the period.
The United Kingdom is anticipated to lead the European market during the forecast period. Stimulating the occurrence of atrial fibrillation and growth in healthcare awareness are propelling the market in the region. Available funds for research programs being organized by the government and other private organizations are accelerating the market growth throughout the period. Moreover, factors like anxiety, stress, and lifestyle changes and augmenting the number of heart patients are likely to drive the market further. Germany is expected to witness notable growth in the region due to increasing patient count and adopting sedentary lifestyles.
Key Market Companies leading the Europe Atrial Fibrillation Surgery Market profiled in the Report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org